Loading...
Loading...
BPC-157 & TB-500 Blend — Tissue Repair & Angiogenesis Research
Select Size
The BPC-157 and TB-500 combination is widely studied as a recovery-focused peptide blend that pairs two compounds with complementary tissue repair mechanisms in a single research formulation. BPC-157 (Body Protection Compound-157), a pentadecapeptide derived from gastric juice proteins, has been investigated for its ability to modulate growth factor expression including VEGF, FGF, and EGF while exerting potent anti-inflammatory effects through nitric oxide system regulation and NF-kB pathway modulation. TB-500 (Thymosin Beta-4), a 43-amino-acid peptide naturally present in most tissues, is researched for its role in promoting angiogenesis, upregulating actin polymerization, and facilitating cell migration to injury sites. The rationale for combining these two peptides lies in their non-overlapping yet synergistic pathways: BPC-157 addresses the inflammatory cascade and growth factor signaling at the wound site while TB-500 provides the structural and vascular support necessary for new tissue formation. Published research suggests this dual approach may accelerate repair across multiple connective tissue types including tendons, ligaments, muscles, and joints. Each vial contains BPC-157 (5mg) and TB-500 (5mg) blended under sterile conditions, with both components individually verified at 99%+ purity before formulation.
Published research protocols reference daily subcutaneous administration. Store refrigerated at 2-8°C. Rotate injection sites.
Published research protocols reference daily administration in 4-8 week cycles. Contains BPC-157 (5mg) and TB-500 (5mg). Consult applicable literature for specific research applications.
BPC-157 and TB-500 operate through distinct but complementary repair pathways, with BPC-157 modulating growth factor cascades and inflammation while TB-500 promotes actin-based cell migration and new blood vessel formation. This dual-mechanism approach has been studied for its potential to produce more comprehensive tissue repair outcomes than either peptide alone.
Initial effects within first month
Research has examined this blend across a broad range of connective tissue types including tendons, ligaments, skeletal muscle fibers, joint capsules, and gastrointestinal mucosa. The versatility stems from both peptides acting on fundamental cellular repair processes such as growth factor signaling and cytoskeletal reorganization rather than tissue-specific pathways.
Initial effects within first month
BPC-157 has been researched for its ability to downregulate pro-inflammatory cytokines and modulate the nitric oxide system, while TB-500 has been studied for reducing inflammatory mediators at wound sites. Together, they target multiple nodes in the inflammatory cascade, which may help create a more favorable environment for tissue regeneration.
Initial effects within first month
This blend contains BPC-157 (Body Protection Compound-157) at 5mg and TB-500 (Thymosin Beta-4) at 5mg per vial. BPC-157 is a 15-amino-acid synthetic peptide derived from a protective gastric protein sequence, while TB-500 is a 43-amino-acid peptide that plays a role in actin regulation and cell motility. Both components are synthesized individually, verified at 99%+ purity via HPLC and mass spectrometry, and then combined under sterile conditions.
BPC-157 has been researched for modulating growth factors (VEGF, FGF, EGF) and reducing inflammation through nitric oxide and NF-kB pathway interactions. TB-500 has been studied for promoting angiogenesis and facilitating cell migration via actin polymerization. The rationale for combining them is that BPC-157 addresses the biochemical signaling environment at injury sites while TB-500 provides the structural cellular mechanisms for new tissue formation, creating a more comprehensive approach to tissue repair research.
Store the lyophilized (unreconstituted) BPC-TB blend at -20°C for maximum long-term stability, or at 2-8°C if it will be used within a few weeks. After reconstitution with bacteriostatic water, refrigerate at 2-8°C, protect from light, and use within 30 days. Do not freeze reconstituted solution as this can damage peptide structure. Both BPC-157 and TB-500 are relatively stable peptides, but the blend should still be handled with standard peptide storage protocols.
Reconstitute with bacteriostatic water by gently directing the stream down the inside wall of the vial. Swirl gently to dissolve — never shake, as this can denature the peptides. Typical reconstitution volumes range from 1-2ml depending on the desired concentration for your research protocol. Since this blend contains two peptides already in precise ratios, no additional mixing or calculation is required. Use sterile technique throughout the process.
No. This product is sold exclusively for in-vitro research, laboratory investigation, and educational purposes. It is not approved for human consumption, clinical use, or self-administration. Researchers should consult all applicable institutional guidelines and jurisdictional regulations before incorporating this blend into any research protocol.
Important Notice
Not for human consumption. This product is sold exclusively for in-vitro research and laboratory use. It is not a drug, supplement, food item, or cosmetic and has not been evaluated by the FDA.
The research data and clinical references cited on this page are provided for educational reference only and do not constitute medical advice. This product must be handled by qualified research professionals in accordance with all applicable institutional and regulatory guidelines.
Use is restricted to qualified researchers or laboratories operating within appropriate legal and ethical research guidelines. By purchasing, you confirm you are acquiring this product solely for lawful research purposes.
Published research and educational content related to Wolverine
A detailed comparison of two of the most studied recovery peptides in preclinical research, examining their distinct mechanisms, published findings, and how investigators approach studying them individually and in combination.
A review of preclinical research on peptides like BPC-157 and TB-500 and their potential roles in tissue repair and recovery processes.
A comprehensive look at the scientific literature behind BPC-157, one of the most studied peptides for tissue repair and recovery.
New to the world of peptides? This guide covers the fundamentals of peptide science, their biological roles, and why they have become a focus of modern wellness research.